France· FR:63898512
RIFINAH 300 mg/150 mg, comprimé enrobé
A medicinal product containing rifampicine + isoniazide, registered in France by SANOFI WINTHROP INDUSTRIE, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- RIFAMPICINE + ISONIAZIDE
- Manufacturer
- SANOFI WINTHROP INDUSTRIE
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip133400932954094plaquette(s) thermoformée(s) PVC PVDC aluminium de 30 comprimé(s)EUR 18.04
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Rifampicine + isoniazide in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomRifamazid 150mg/100mg capsulesImported (Poland)
- NorwayRifinahsanofi-aventis (2)
- SwitzerlandRifinah, comprimés enrobésSanofi-Aventis (Suisse) SA
- IrelandRifinah 150/100 mg Film- Coated TabletsSanofi-Aventis Ireland Limited T/A SANOFI
- NetherlandsRifinah 300 mg/150 mg, filmomhulde tabletSanofi B.V.
- PolandRifamazidTarchomińskie Zakłady Farmaceutyczne "Polfa" S.A.
- SwedenRimactazid 150 mg/75 mg Filmdragerad tablettSandoz A/S
- FinlandRimactazidSandoz A/S
Authorised across Europe · EMA
The same active substance is authorised in 17 EEA countries. Names it is sold under:
- Austria · Rifoldin Mit Inh
- Cyprus · Rifamazid
- Denmark · Rimactazid
- Spain · Rifinah
- United Kingdom (Northern Ireland) · Rifinah
- Greece · Rifinah
- Hungary · Rifazid
- Ireland · Rifinah
- Italy · Rifinah
- Lithuania · Rifamazid
- Netherlands · Rifinah
- Norway · Rimactazid
- Poland · Rifamazid
- Portugal · Rifinah
- Romania · Sinerdol Iso
- Sweden · Rimactazid
- Slovenia · Rifinah
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/03adae6b-34c8-4e2f-8d9c-1c057b6dc2e4 GET /v1/drugs/03adae6b-34c8-4e2f-8d9c-1c057b6dc2e4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "63898512",
"date_amm": "1987-04-22",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "RIFAMPICINE + ISONIAZIDE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé enrobé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about rifampicine + isoniazide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.